Skip to main content
XAIR
NASDAQ Industrial Applications And Services

Stockholders Approve Equity Incentive Plan, Authorizing 850,000 New Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.15
Mkt Cap
$9.211M
52W Low
$0.673
52W High
$10.4
52W Position info
71% above low
Off High info
89% below high
Rel. Volume
Market data snapshot near publication time

XAIR sits 71% above its 52-week low of $0.673.

Summary

Beyond Air stockholders approved an amendment to its equity incentive plan, authorizing an additional 850,000 shares, representing over 10% potential dilution.


Key Events · Financing and Capital Events · XAIR

  • Equity Incentive Plan Expanded

    Stockholders approved the Eighth Amended and Restated 2013 Equity Incentive Plan, increasing the number of shares reserved for issuance by 850,000. This represents a potential dilution of approximately 10.6% based on shares outstanding as of December 3, 2025.

  • Directors Re-elected

    Six nominees for director were elected to serve until the next annual meeting, including Steven A. Lisi, Robert S. Goodman, Robert F. Carey, Dr. William Forbes, Yoori Lee, and Erick J. Lucera.

  • Auditor Ratified

    The appointment of WithumSmith+Brown, PC as the company's independent registered public accounting firm for the fiscal year ending March 31, 2026, was ratified by stockholders.


Analysis · XAIR · Industrial Applications And Services

Beyond Air, Inc. stockholders approved an amendment to its Equity Incentive Plan, reserving an additional 850,000 shares for issuance. This represents a significant potential dilution of over 10% based on current outstanding shares and market capitalization. While equity incentive plans are common for employee motivation, the substantial increase in authorized shares for a company of this size could create an overhang on the stock. This approval follows recent capital-raising activities, including a $5.0 million private placement announced on January 20, 2026, and an S-3 registration statement filed on January 30, 2026, for the resale of common stock and warrants, indicating a continued focus on strengthening the company's financial position.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XAIR was trading at $1.15 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.2M. The 52-week trading range was $0.67 to $10.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XAIR - Latest Insights

XAIR
Aug 31, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.73
Real-time Price: $3.11 info
Change: -$2.62 (-46%) info
Market Cap: $3.062M info
XAIR
Aug 25, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.78
Real-time Price: $3.11 info
Change: -$1.67 (-35%) info
Market Cap: $3.062M info
XAIR
Aug 24, 2026, 5:25 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $4.91
Real-time Price: $3.11 info
Change: -$1.80 (-37%) info
Market Cap: $3.062M info
XAIR
Aug 18, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.73
Real-time Price: $3.11 info
Change: -$2.62 (-46%) info
Market Cap: $3.062M info
XAIR
Aug 17, 2026, 4:50 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $5.71
Real-time Price: $3.11 info
Change: -$2.60 (-46%) info
Market Cap: $3.062M info